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Abstract
Our objective was to determine the expression of the elements of the Lin28/Let-7 system, and related microRNAs (miRNAs),
in early stages of human placentation and ectopic pregnancy, as a means to assess the potential role of this molecular hub
in the pathogenesis of ectopic gestation. Seventeen patients suffering from tubal ectopic pregnancy (cases) and forty-three
women with normal on-going gestation that desired voluntary termination of pregnancy (VTOP; controls) were recruited for
the study. Embryonic tissues were subjected to RNA extraction and quantitative PCR analyses for LIN28B, Let-7a, miR-132,
miR-145 and mir-323-3p were performed. Our results demonstrate that the expression of LIN28B mRNA was barely
detectable in embryonic tissue from early stages of gestation and sharply increased thereafter to plateau between
gestational weeks 7–9. In contrast, expression levels of Let-7, mir-132 and mir-145 were high in embryonic tissue from early
gestations (#6-weeks) and abruptly declined thereafter, especially for Let-7. Opposite trends were detected for mir-323-3p.
Embryonic expression of LIN28B mRNA was higher in early stages (#6-weeks) of ectopic pregnancy than in normal
gestation. In contrast, Let-7a expression was significantly lower in early ectopic pregnancies, while miR-132 and miR-145
levels were not altered. Expression of mir-323-3p was also suppressed in ectopic embryonic tissue. We are the first to
document reciprocal changes in the expression profiles of the gene encoding the RNA-binding protein, LIN28B, and the
related miRNAs, Let-7a, mir-132 and mir-145, in early stages of human placentation. This finding suggests the potential
involvement of LIN28B/Let-7 (de)regulated pathways in the pathophysiology of ectopic pregnancy in humans.
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Introduction
Ectopic pregnancy is an important cause of maternal morbidity
and mortality whose etiology is still unknown. It is a condition in
which a fertilized ovum does not implant into the uterine cavity,
being the most common site of ectopic implantation the Fallopian
tube [1]. Its incidence is 1–2% of all reported pregnancies [2], and
it is the main cause of maternal death in early stages of pregnancy
(4–10% of deaths related to pregnancy) [3]. Given the impact of
this pregnancy disease in reproductive success and maternal
outcomes, and considering of the conspicuous lack of accurate and
early markers [3], a better understanding of the molecular
mechanisms involved in this condition is eagerly needed. To
accomplish this goal, deepening of our physiological knowledge of
the early events of normal human placentation becomes also
mandatory.
Recent evidence has conclusively demonstrated that the
regulation of numerous key biological processes does not depend
only of classical transcriptional mechanisms, and other regulatory
phenomena, such as epigenetic mechanisms, do have important
roles [4]. These epigenetic mechanisms include not only DNA
methylation and the post-translational modifications of histones,
but also small non-coding RNAs, including microRNAs [4,5].
MicroRNAs (miRNAs) are small RNA fragments (18 to 25
nucleotides) that do not encode proteins but act as post-
transcriptional regulators of many gene targets [6,7]. The number
of known miRNAs in different species, including humans, has
exponentially increased in recent years [8], and to date, nearly one
thousand individual miRNAs have been identified in humans. The
interest in this class of regulatory molecules has also dramatically
expanded recently, as they have been shown to be involved in the
regulation of key biological phenomena, including cellular
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stemness, proliferation, apoptosis and differentiation [9], while
their deregulation is thought to play important pathogenic roles in
multiple diseases, including prominently cancer, as well as sepsis,
autoimmune diseases and some cardiovascular and metabolic
disorders [10].
The main mechanism used by miRNAs for gene regulation is
related with their binding capacity to complementary sequences of
RNAs, mainly located in the 39-untranslated regions, causing (in
most cases) gene silencing. A remarkable feature of miRNAs is that
they are rather stable and detectable in circulation and other body
fluids, thus opening up the possibility of their use as biomarkers of
specific disease conditions [10]. Indeed, the recent identification of
circulating pregnancy-associated microRNAs has raised consider-
able interest, as they may help in the early diagnosis (and the
eventual etiopathogenic characterization) of complications related
to pregnancy [9,11–13].
The family of Let-7 is a numerous group of related miRNAs,
encoded by various gene clusters, which is among the most highly
expressed in mammals [14]; in humans, up to 11 different let-7
members encoded by 4 gene clusters have been identified.
MiRNAs of the Let-7 family have been shown to participate in
the control of cellular pluripotency, proliferation and differentia-
tion [15,16]. Besides their key roles during development and
gametogenesis, Let-7 miRNAs have been cataloged as tumor
suppressors, whose deregulation may lead to tumorigenesis
[15,16]. In fact, different oncogenes, such as such as c-Myc, Ras
and Cdk6 are known targets of Let-7 miRNAs.
LIN28 is a RNA binding-protein that is thought to play
important roles during development [17], pubertal maturation
[18–20], and in the control of spermatogonial stemness [21,22],
among other functions. Two LIN28-related genes, namely LIN28
(or LIN28A) and LIN28B, are found in mammals [23–25]. LIN28
proteins are extensively distributed during mammalian embryonic
maturation, but its expression becomes restricted to some tissues in
adulthood [26]. LIN28 proteins are capable of binding the
precursors of Let-7 miRNAs, thus blocking their capacity to
interact with the miRNA-maturing enzyme, Dicer, and preventing
their processing into mature miRNAs [17]. In turn, Let-7 miRNAs
participate in the regulation of LIN28 expression, which is
controlled also by other upstream elements, such as myc, and,
according to bioinformatics predictions, other miRNAs, as mir-132
and mir-145, thus forming a complex regulatory hub that is
involved in different processes [19].
In spite of their paramount importance and the concurrence of
complex developmental phenomena, the roles of miRNA regula-
tory pathways in human placentation and early pregnancy remain
largely unknown [27], even though placental formation resembles
features of tumor progression and invasiveness; phenomena in
which miRNAs have been shown to play important regulatory
roles. Nonetheless, significant progress in our knowledge of the
involvement of miRNAs in human pregnancy has occurred
recently, as various pregnancy-associated miRNAs clusters have
been identified [9]. Moreover, a number of circulating, pregnancy-
specific miRNAs have been reported; a finding that has drawn
considerable interest as these may serve as potential biomarkers of
different gestational complications [11,27]. Yet, a majority of the
expression studies published have focused in late stages of
pregnancy, and little attention has been paid so far to the
characterization of the expression patterns of specific miRNAs in
early phases of human placental formation. As illustrative
example, the expression of Let-7 miRNAs and LIN28 has been
recently reported in human gestational tissues at term [28].
However, no information regarding the expression of the elements
of the LIN28/Let-7 system in human placenta at early stages of
gestation is available. Similarly, despite very recent findings on
circulating mir-323-3p as putative biomarker of ectopic pregnancy
[29], to our knowledge, no information has been so far reported on
changes of expression in ectopic placental tissue of miRNAs in
general, and of the elements of the LIN28/Let-7 system in
particular.
In this context, the aim of this work is to evaluate the expression
patterns of LIN28B mRNA, as well as the related Let-7, mir-132
and mir-145, in human embryonic tissue from early gestation,
between weeks 5 and 9 of amenorrhea. In addition, changes in the
expression of the above targets were explored in embryonic
material from ectopic pregnancies, at this early gestational
window. For comparative purposes, the embryonic expression
levels of the recently proposed circulating biomarker of ectopic




The present study was approved by the Institutional Review
Board/Independent Ethics Committee of the Hospital Universi-
tario La Fe, Valencia, Spain. Early embryonic tissue (mostly
trophoblast) was collected after obtaining the corresponding
informed consent from each patient.
Human Samples
Forty-three women with a normal ongoing pregnancy that
desired a voluntary termination of pregnancy (VTOP) and
seventeen patients suffering from tubal ectopic pregnancy were
recruited (Table 1). Patients were diagnosed of suspected ectopic
pregnancy by using transvaginal ultrasound combined with serial
determinations of blood BhCG. The patients provided the date of
their last menstrual period. Diagnostic confirmation and treatment
were done by laparoscopy; laparoscopic procedure was elected as
the patients did not meet criteria for medical treatment, namely:
hemodynamic instability, hemo-peritoneum, diameter of ectopic
pregnancy larger than 4 cm, presence of heartbeat, severe pain,
BhCG concentrations greater than 5000 UI/L [2]. None of them
had received pre-operatively any medical treatment with metho-
trexate.
After signing the informed consent to participate in the study
and for the intervention, a laparoscopic procedure was performed,
using conventional techniques. Ectopic pregnancies selected for
this study were unruptured gestations located in the isthmus or the
proximal ampulla. The tube containing the ectopic pregnancy was
grasped at both sites (approximately 1 cm away from the gestation)
and bipolar coagulation applied. Similarly, the adjacent mesentery
was also coagulated. Then, salpingectomy was performed
employing scissors. One of the investigators present in the
operating room (TL) perform a longitudinal incision to the anti
mesentery surface of the tube and applied a mild pressure with two
fingers to extract the gestational sac. Embryonic tissue was
carefully separated from obvious blood clots and tubal tissue in the
operating room under a stereomicroscope. Embryonic samples
were immediately placed in TRIzol reagent (see below), frozen and
stored at 280uC until use. A piece of sample was sent to the
Pathology Department (Hospital Universitario La Fe), which
provided histological confirmation of ectopic pregnancy and
absence of tubal tissue. Fetal dilation and evacuation method or
fetal aspiration technique were performed in VTOP women to
obtain Embryonic tissue. Tissue samples were immediately stored
at 280uC until use.
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RNA Extraction and Quantitative PCR
Total RNA was isolated from human embryonic samples from
different stages of pregnancy (both control and ectopic gestations),
using TRIzol reagent (Invitrogen, CA), following the manufactur-
er’s protocol. The quality and concentration of the isolated RNA
were determined by spectrophotometry, following standard
procedures. Real-time qPCR was performed on the samples using
a Bio-Rad SFX 96 Real-Time System (Bio-Rad Laboratories,
Hercules, CA), as described in detail elsewhere [19,22].
For quantification of LIN28B mRNA in embryonic samples,
1 mg of total RNA per tissue sample was treated with RQ1
RNAse-free DNAse-I (Promega, Madison, WY) and retro-
transcribed (RT) in a 30 ml reaction using iScriptTM Reverse
Transcription Super-mix (Bio-Rad Laboratories). For real-time
PCR amplification, we used SYBR Green qPCR Master Mix
(Promega), with the following primer sequences: hLIN28B-
forward: 59-CAT CTC CAT GAT AAA CCG AGA GG-39;
hLIN28B-reverse: 59-GTT ACC CGT ATT GAC TCA AGG C-
39. The primer pair: hL19-forward: 59-GAA ATC GCC AAT
GCC AAC TC-39 and hL19-reverse: 59-ACC TTC AGG TAC
AGG CTG TG-39 was used for amplification of a 290-bp
fragment of the mRNA of ribosomal L19 protein, used as internal
control for reaction efficiency and sample loading.
PCR was initiated by one cycle of 95uC for 2-minutes, followed
by 35 cycles of 15-seconds at 95uC, 30-seconds at 62uC, and 10-
seconds at 72uC, followed by one final cycle of 72uC for 1-minute.
Relative LIN28 mRNA levels were normalized against the
expression levels of L19 internal control transcript.
For miRNA analyses, expression levels of Let-7a, mir-145, mir-
132 and mir-323-3p were assayed, following a previously published
procedure [19]. cDNA was synthesized by using 10 ng total RNA
with TaqMan–specific RT primers and the TaqMan microRNA
reverse transcription kit (Applied Biosystems, Foster City, CA).
Thereafter, quantitative RT PCR was performed using pre-
designed assays for Let-7a, mir-145, mir-132, mir-323-3p and RNU6
(Applied Biosystems). PCR reactions were carried out as follows:
50uC for 2-minutes, 95uC for 10-minutes, followed by 40 cycles of
95uC for 15-seconds and 60uC for 1 minute. For quantitative
miRNA determination, RNU6 gene served as internal control
reference.
Presentation of Data and Statistics
Hormonal data are presented as mean 6 SEM. Results were
statistically analyzed using one-way ANOVA (for studies on
expression profiles in normal pregnancies in which the variable
was the gestational age; see Figure 1) or two-way ANOVA (for
comparison of expression levels as function of gestational age and
ectopic placentation; Figures 2–3), in order to detect inter-group
differences. If significant interactions were found, the data were
further analyzed using post hoc comparisons (using Newman-
Keuls tests), in order to identify simple effects. Statistical analyses
were conducted following the procedures of the software package
Prism-GraphPad (La Jolla, CA, USA). P-values #0.05 were
considered statistically significant.
Results
Embryonic Tissue Expression of LIN28B and Related
miRNAs during Early Human Gestation
Embryonic tissues from early stages of normal gestation
(between 5- and 9-weeks after amenorrhea) were studied. Given
the limited number of samples available, and in order to increase
statistical power, samples from 5- and 6-weeks were grouped for
analysis as #6-weeks samples. Investigation of the relative mRNA
levels of the RNA-binding protein, LIN28B, in early human
embryonic tissue revealed nearly negligible expression in #6-week
placentas, with a sharp increase of LIN28B mRNA levels at week-7
and plateau levels thereafter up to week-9 (Figure 1A). In clear
contrast, Let-7a miRNA expression was maximal in #6-week
embryonic tissue, and abruptly dropped in the transition to week-
7, to remain low in expression up to week-9 (Figure 1B). A similar
profile was observed for mir-132 and mir-145, although the decline
in expression was more gradual and less pronounced (e.g., on
week-7, mean Let-7 levels were reduced in .80%, while mir-132
and mir-145 levels were nearly halved), and in the case of mir-
145 only reached statistical significance on week-8 (Figure 1C–
D). On the other hand, an inverse trend was detected for mir-323-
3p, whose expression levels were minimal in #6-week embryonic
tissue, and increased thereafter, with maximal mean levels at
week-9. Yet, due to some variability within groups, these
differences did not reach statistical significance when compared
on a weekly basis (Figure 1E).
Embryonic Tissue Expression of LIN28B and Related
miRNAs in Ectopic Pregnancies
The expression levels of the above targets were comparatively
analyzed in embryonic tissues from ectopic pregnancies, during
this early developmental window. While samples were assayed
individually, in order to increase the statistical power of our
analyses, values were grouped into #6-week vs. 7–9 week samples
for comparison. This procedure allowed to increase the number of
individual determinations per group and was based on the trends
observed from individual sample analyses.
Grouped analysis of the expression values confirmed that
LIN28B mRNA expression increases (by nearly 4-fold) in normal
embryonic tissue between #6-week and later stages of early
gestation. Notably, LIN28B mRNA levels in embryonic tissue from
#6-week ectopic pregnancy were significantly higher than in the
control group, while this difference obliterated in 7–9 week
samples (Figure 2A). Quite oppositely, we detected a substantial
drop in Let-7 miRNA levels in normal embryonic tissue between
#6-week and later stages of gestation (in keeping with individual
























EP 30,9 2,1 0,5 35,3% 0,5 11,8% 35,3% 11,6% 5,9% 23,5%
Controls 21,1 2 0,5 38,2% 0,4 2,9% 11,8% 0% 2,9% 47,1%
doi:10.1371/journal.pone.0087698.t001
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analyses), while in ectopic pregnancies, Let-7a miRNA expression
was already very low in #6-week samples (Figure 2B).
Similar analyses were conducted for the other miRNA targets.
Expression levels of mir-132 and mir-145 declined between #6-
week and later stages of early gestation, and these profiles were not
substantially altered in ectopic gestation (Figure 3A–B), although
a non-significant trend for higher levels of mir-145 in #6-week
ectopic embryonic tissue was detected. In contrast, mir-323-3p
expression levels raised in normal human embryonic tissue
between #6-week and later stages of early gestation; a difference
that was statistically significant due to the grouped analysis of the
samples (#6-week vs. 7–9 week groups). Interestingly, mir-323-3p
levels were similar in normal and ectopic gestation at #6-weeks;
yet, the rise of expression detected at later stages of normal early
gestation was not observed in ectopic pregnancies, so that mir-323-
3p levels in 7–9 week ectopic embryonic tissue were significantly
lower than in the control group (Figure 3C).
Discussion
Ectopic pregnancy is a rather common condition that represents
the major cause of maternal death during early stages of
pregnancy, for which improved diagnostic tools are eagerly
needed. In current practice, diagnosis of ectopic pregnancy
requires multiple clinic visits [30], and quite often needs
laparoscopy as method of certainty, with the risks associated to
this intervention and the negative maternal psychological and
reproductive consequences that it entails. These above reasons
justify the active search for non-invasive, accurate methods for
diagnosis of ectopic pregnancy, whose identification should be
Figure 1. Expression profiles of LIN28B and several miRNAs in
embryonic tissue during normal placentation at early gesta-
tional periods. Relative mRNA and miRNA levels were assayed in
placental samples from normal pregnancies, obtained from women
undergoing voluntary termination of pregnancy (VTOP) at gestational
ages ranging from week-5 to week-9 after amenorrhea. Samples from
week-5 and 26 of amenorrhea were grouped as #6-week gestational
samples. Targets analyzed were: LIN28B (A), Let-7a (B), mir-132 (C), mir-
145 (D) and mir-323-3p (E). Data are presented as mean 6 SEM.
Expression levels were quantitatively analyzed using the 2DDCt method
and were normalized to values from #6-week gestational samples. *,
P,0.05; **, P,0.01; and ***, P,0.001 vs. values in #6-week gestational
samples (One-way ANOVA followed by Newman-Keuls test).
doi:10.1371/journal.pone.0087698.g001
Figure 2. Altered expression of LIN28B and Let-7a in embry-
onic tissue from early ectopic pregnancies. Relative levels of
LIN28B mRNA (A) and Let-7 miRNA (B) were assayed in samples from
VTOP controls and ectopic pregnancy patients. For presentation, the
data were grouped in two gestation age ranges: #6-week vs. 7–9 week
gestational samples. Data are presented as mean 6 SEM. Expression
levels were quantitatively analyzed using the 2DDCt method and were
normalized to values from #6-week VTOP (control) samples. Data were
analyzed by two-way ANOVA, followed by individual Newman-Keuls
tests; **, P,0.01 vs. corresponding values in control samples (effect of
EP); a, P,0.01 vs. corresponding values in ,6-week samples (effect of
gestational age).
doi:10.1371/journal.pone.0087698.g002
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based in a better understanding of the early stages of human
placentation and the pathophysiological mechanisms underlying
this disease.
Considering that placental formation displays features that
resembles those of tumor progression and invasiveness, as well as
complex developmental processes (phenomena in which miRNA
regulatory pathways seem to play an essential role), it is reasonable
to hypothesize that specific miRNAs might be involved in the
regulation of placentation and pregnancy in humans and other
species. Indeed, a number of studies have addressed the roles of
miRNAs in human gestation [9,11,27], and specific pregnancy-
associated miRNA-clusters and circulating miRNAs have been
identified, which pose obvious pathophysiological interest and may
pave the way for the identification of improved biomarkers of
gestational complications. On the latter, however, little attention
have been paid so far to ectopic pregnancy, and to our knowledge
only one study have been reported on the potential usefulness of
circulating mir-323-3p as biomarker of ectopic pregnancy [29].
Yet, this observation has not been independently confirmed.
Likewise, no comparative reports on the patterns of early
embryonic tissue expression of specific miRNAs during early
normal gestation and ectopic pregnancy have been presented to
date. These studies may help to elucidate key pathogenic
mechanisms and would illuminate the search for additional
miRNA-related biomarkers of this condition.
In this work, we evaluated the expression patterns of LIN28B,
Let-7a and related miRNAs in embryonic tissues from normal and
ectopic pregnancies during early stages of gestation; i.e., 5–9 weeks
after amenorrhea. Embryonic tissue from ectopic gestations and
matched ongoing pregnancies subjected to VTOP, as representa-
tive of normal implantation, were studied. The latter were used as
controls since these pregnancies were viable, with a theoretically
healthy trophoblast with normal implantation, thereby eliminating
external factors such as chromosomal abnormalities, toxics,
thrombophilias, and any other perturbations that might lead to
a spontaneous abortion and could produce also changes in the
pathways under investigation.
Our analyses unveiled that very early (#6-week) normal
embryonic tissue expresses virtually negligible levels of LIN28B
but maximal levels of Let-7a, as well as mir-132 and mir-145. Of
note, expression of LIN28 and members of the Let-7 family had
been previously reported in the placenta of rats and humans
[19,28], but to our knowledge those analyses were restricted to
gestational tissues at term and no information on early expression
profiles was available. Transition between gestational week-6 to
week-7 brought about a marked reciprocal change in the
expression of those targets, with a robust increase in LIN28B
mRNA expression and a significant decrease of Let-7a, and to a
lesser extent mir-132 and mir-145 levels. Changes in LIN28 and
Let-7 expression have been related with tumorigenesis and cancer
invasiveness. Thus, LIN28B over-expression has been detected in
several tumors and hematological malignancies [31], suggesting a
role of this molecule in (promoting) invasiveness. In turn, Let-7
miRNAs have been reported to play role as tumor suppressor,
mainly by repression of oncogenes and key regulators of various
mitogenic pathways, such as Myc, Hmga2, Ras, JAK and STAT3.
All in all, it might be speculated that an increase in the LIN28B/
Let-7 ratio, as observed during the 6-to-7 gestational week
transition, might be associated with a pro-proliferative and
invasive phenotype. It is tempting to hypothesize that this change
might play a role in trophoblast invasion and placental formation
during this early gestational period, through as yet unknown
effector mechanism. The regulatory roles in early placentation of
mir-132 and mir-145, whose levels also decline during this time-
window and are predicted to participate in the regulation of
LIN28B synthesis [19], merit further investigation.
Tubal ectopic implantation resulted in the reversal of the
expression profiles of LIN28B and Let-7a in early (#6-week)
embryonic tissue. Thus, in ectopic embryonic tissue for #6-week
gestation LIN28B mRNA levels were abnormally high, and
remained high in 7–9 week embryonic tissue. Conversely, Let-7a
miRNA expression was already suppressed in #6-week samples
from ectopic pregnancies, so that this condition anticipated the
drop of expression of this miRNA that normally occurred from
week-7 onwards. These expression profiles would imply an
increased LIN28B/Let-7 ratio in embryonic tissue from #6-week
ectopic gestations. Assuming that this ratio might favor a pro-
proliferative and invasive phenotype, it is tenable that such a
deregulation in the LIN28/Let-7 system might contribute to the
perturbation of trophoblast invasion that characterizes ectopic
pregnancies. Admittedly, our analyses using homogenates of early
embryonic tissue do not allow discrimination of the specific
cellular sources for the expression of LIN28B and Let-7a targets.
Figure 3. Expression profiles of mir-132, mir-145 and mir-323-
3p in embryonic tissue from early ectopic pregnancies. Relative
levels of mir-132 mRNA (A), mir-145 and mir-323-3p (B) were assayed in
embryonic samples from VTOP controls and ectopic pregnancy
patients. For presentation, the data were grouped in two gestation
age ranges: #6-week vs. 7–9 week gestational samples. Data are
presented as mean 6 SEM. Expression levels were quantitatively
analyzed using the 2DDCt method and were normalized to values from
#6-week VTOP (control) samples. Data were analyzed by two-way
ANOVA, followed by individual Newman-Keuls tests; **, P,0.01 vs.
corresponding values in control samples (effect of EP); a, P,0.01 vs.
corresponding values in ,6-week samples (effect of gestational age).
doi:10.1371/journal.pone.0087698.g003
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Yet, the reported reciprocal changes between LIN28B and Let-7a
both during early pregnancy and in ectopic placentas strongly
suggest that these two factors are co-localized, further stressing the
functional relevance of this reciprocal regulation. Indeed, the
major known function of LIN28B is to repress the maturation of
Let-7 miRNAs [17].
As mentioned above, mir-323-3p is the only putative biomarker
of ectopic pregnancy reported to date [29]. However, identifica-
tion of this marker was done in plasma and no information
regarding its expression patterns in normal and ectopic placentas is
available. Our comparative analyses revealed that, in contrast to
Let-7a, mir-132 and mir-145, the embryonic expression of mir-323-
3p increased during early pregnancy, with minimal levels being
detected in #6-week embryonic tissue that raised thereafter. Quite
unexpectedly, despite the reported increase in the circulating levels
of this miRNA in ectopic pregnancy, our data evidenced that
ectopic embryonic tissue actually expressed lower levels of mir-323-
3p from week-7 onwards, so that the raise in mir-323-3p expression
observed in normal gestation is not detected in ectopic pregnan-
cies. Thus, although mir-323-3p has been proposed as pregnancy-
specific miRNA (32), our results cast doubt on the placental origin
of the excess of this factor in ectopic gestation. In fact, the
possibility that the source of circulating mir-323-3p in ectopic
pregnancy might not be solely the embryonic tissue has been
already suggested [29,32]; our findings support the non-embryonic
origin of this miRNA and call for independent confirmation of the
usefulness of plasma levels of mir-323-3p as universal marker of
ectopic gestation.
In sum, we document herein the expression profiles of elements
of the Lin28/Let-7 system, as well as related miRNAs, in
embryonic tissue during early stages of normal gestation and
ectopic pregnancy. Our data are the first to disclose the opposite
patterns of embryonic expression of LIN28B and Let-7a during
early pregnancy, with an increased ratio of LIN28B/Let-7a levels in
the embryonic tissue during the 6- to 7-week transition, while
ectopic embryonic tissue displayed high LIN28B/Let-7a ratios
already on #6-week gestational ages. Given the proposed roles of
LIN28 and Let-7 members in the control of cellular proliferation
and tumor invasion, its is tempting to propose that the above
changes in LIN28B and Let-7a expression might play a role in the
control of normal and ectopic placentation.
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